ABTEC — Aqua Bio Technology ASA Share Price
0.000.00%
Last trade - 00:00- NOK292.42m
- NOK315.20m
- NOK7.02m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 38.07 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 21.64 | ||
| EV to EBITDA | 67.51 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 6.96% | ||
| Return on Equity | -19.67% | ||
| Operating Margin | 17.03% | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | NOKm | 0.88 | 0.89 | 0.44 | 1.56 | 7.02 | n/a | n/a | 42.04% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Aqua Bio Technology ASA is a Norway-based skincare company. The Company develops and commercializes sustainable biotechnology for use in skin care products. ABT develops new active ingredients for skincare based on marine technology with documented positive effects on human skin. The ingredients are based on natural and sustainable substances, found in plants, algae and in the oceans and provide the cosmetics industry with natural alternatives to traditional ingredients. In addition to ingredients from its own technology, ABT also markets and distributes natural skincare products to consumers, retailers and professional users in Europe and the Middle East. The ABT portfolio of skincare products contains exclusive and high-end products as well as off the shelf products. They are distributed over the Internet, in stores and through professional channels such as skincare clinics.
Directors
- Edvard Cock CHM (47)
- Havard Lindstrom CEO
- Espen Kvale COO
- Hans Leren CTO
- Arvid Lindberg DSL (44)
- Kristin Aase DRC (55)
- Tone Bjornov DRC (60)
- Roger Hofseth DRC (45)
- Jan Pettersson DRC (62)
- Last Annual
- December 31st, 2022
- Last Interim
- June 30th, 2023
- Incorporated
- March 9th, 2004
- Public Since
- January 10th, 2008
- No. of Employees
- 2
- Sector
- Personal & Household Products & Services
- Industry
- Consumer Defensives
- Exchange
- Oslo Stock Exchange
- Shares in Issue
- 56,234,479
- Address
- Fornebuveien 37, LYSAKER, 1366
- Web
- https://aquabiotechnology.com/
- Phone
- +47 98245410
- Auditors
- RSM Norge AS
Upcoming Events for ABTEC
Similar to ABTEC
Ecit AS
Oslo Stock Exchange
Lumi Gruppen AS
Oslo Stock Exchange
FAQ
What is the Aqua Bio Technology ASA share price?
As of Today at 19:02 UTC, shares in Aqua Bio Technology ASA are trading at NOK5.20. This share price information is delayed by 15 minutes.
How has the Aqua Bio Technology ASA share price performed this year?
Shares in Aqua Bio Technology ASA last closed at NOK5.20 and the price had moved by -9.89% over the past 365 days. In terms of relative price strength the Aqua Bio Technology ASA share price has underperformed the FTSE Global All Cap Index by -17.45% over the past year.
What are the analyst and broker recommendations for Aqua Bio Technology ASA?
The overall consensus recommendation for Aqua Bio Technology ASA is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Aqua Bio Technology ASA dividend yield?
Aqua Bio Technology ASA does not currently pay a dividend.
Does Aqua Bio Technology ASA pay a dividend?
Aqua Bio Technology ASA does not currently pay a dividend.
When does Aqua Bio Technology ASA next pay dividends?
Aqua Bio Technology ASA does not currently pay a dividend.
How do I buy Aqua Bio Technology ASA shares?
To buy shares in Aqua Bio Technology ASA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Aqua Bio Technology ASA?
As of the previous close price of NOK5.20, shares in Aqua Bio Technology ASA had a market capitalisation of NOK292.42m.
Where are Aqua Bio Technology ASA shares listed?
Here are the trading details for Aqua Bio Technology ASA:
- Country of listing: Norway
- Exchange: OSL
- Ticker Symbol: ABTEC
What kind of share is Aqua Bio Technology ASA?
Based on an overall assessment of its quality, value and momentum Aqua Bio Technology ASA is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Aqua Bio Technology ASA share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the Aqua Bio Technology ASA share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Aqua Bio Technology ASA. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +32.5%.
As of the last closing price of NOK5.20, shares in Aqua Bio Technology ASA were trading +30.63% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Aqua Bio Technology ASA PE Ratio?
The Aqua Bio Technology ASA PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at NOK5.20.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Aqua Bio Technology ASA?
Aqua Bio Technology ASA's management team is headed by:
- Edvard Cock - CHM
- Havard Lindstrom - CEO
- Espen Kvale - COO
- Hans Leren - CTO
- Arvid Lindberg - DSL
- Kristin Aase - DRC
- Tone Bjornov - DRC
- Roger Hofseth - DRC
- Jan Pettersson - DRC